NasoShield in Healthy Adults to Study Safety and Immunogenicity

NCT04415749 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
43
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Altimmune, Inc.

Collaborators